Studio retrospettivo multicentrico internazionale sul sarcoma fibromixoide di basso grado (LGFMS) e sul fibrosarcoma epiteliode sclerosante (SEF)

Title

Code

LGFMS SEF

Type

Osservazionale

Start Year

2023

Status

In Corso

Principal Investigator

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. LGFMS SEF

Tuesday 5 September 2023, 11:26

PG0012734_2023_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

Studio retrospettivo multicentrico internazionale sul sarcoma fibromixoide di basso grado (LGFMS) e sul fibrosarcoma epiteliode sclerosante (SEF)

Principal Investigator

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

Studio retrospettivo multicentrico internazionale sul sarcoma fibromixoide di basso grado (LGFMS) e sul fibrosarcoma epiteliode sclerosante (SEF)

Principal Investigator

Documents and Videos attachament

You might also be interested in